Cancer-associated venous thromboembolism and the non-vitamin K antagonist oral anticoagulants: a review of clinical outcomes and patient perspectives-Reference-Cited by-同舟云学术

Cancer-associated venous thromboembolism and the non-vitamin K antagonist oral anticoagulants: a review of clinical outcomes and patient perspectives

Published:2020-09-24 Issue:11 Volume:18 Page:791-800
ISSN:1477-9072
Container-title:Expert Review of Cardiovascular Therapy
language:en
Short-container-title:Expert Review of Cardiovascular Therapy

Author:

Overvad Thure Filskov¹²,Larsen Torben Bjerregaard¹³^ORCID,Søgaard Mette¹³,Albertsen Ida Ehlers¹³,Ording Anne Gulbech¹³,Noble Simon⁴,Højen Anette Arbjerg¹³,Nielsen Peter Brønnum¹³^ORCID

Affiliation:

1. Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark

2. Department of Oncology, Aalborg University Hospital, Aalborg, Denmark

3. Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark

4. Marie Curie Palliative Care Research Centre, Cardiff University, Cardiff, UK

Funder

Obel Family Foundation

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14779072.2020.1822167

Reference83 articles.

1. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

2. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry

3. Prognosis of Cancers Associated with Venous Thromboembolism

4. Epidemiology of venous thromboembolism in hematological cancers: The Scandinavian Thrombosis and Cancer (STAC) cohort

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positive predictive value and sensitivity of cancer-associated venous thromboembolism diagnoses in the Danish National Patient Register;Thrombosis Research;2024-09

2. Post-pulmonary embolism syndrome: A reminder for clinicians;Asian Cardiovascular and Thoracic Annals;2024-06

3. Direct-Acting Oral Anticoagulant Therapy in Cancer Patients—A Review;Cancers;2023-05-10

4. Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism;Thrombosis Journal;2023-02-02

5. Long-Term Management of Pulmonary Embolism: A Review of Consequences, Treatment, and Rehabilitation;Journal of Clinical Medicine;2022-10-10